Ocular Therapeutix Inc at Cantor Fitzgerald Global Healthcare Conference Transcript

Sep 27, 2023 / 07:00PM GMT
Jennifer Kim Cantor Fitzgerald-Analyst

Okay. Welcome everyone to the Cantor Global Healthcare Conference. I'm Jennifer Kim, a biotech analyst here at Cantor. I'm looking forward to hosting our next fireside chat with Ocular Therapeutix. We have with here -- with us here Anthony Mattessich, CEO. Anthony, thanks for being here.

Anthony Mattessich Ocular Therapeutix - Inc. - President & CEO

Thanks for inviting me.

Jennifer Kim Cantor Fitzgerald-Analyst

Of course. Maybe we can start up. Can you give a introduction of yourself and a brief overview of the company?

Anthony Mattessich Ocular Therapeutix - Inc. - President & CEO

Sure, Antony Mattessich, President and CEO, and in the industry now for 30, 35 years, large and small pharma. I'm always passionate about the idea that we have a lot of good molecules that we've developed, promise people don't take them or take them appropriately, and that the real world benefits of a lot of the things that we have

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
4.6 out of 5 Trustpilot